Literature DB >> 28066748

The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders.

Matthew J Kraeutler1, Tigran Garabekyan2, Omer Mei-Dan3.   

Abstract

BACKGROUND: In recent years, platelet-rich plasma (PRP) has gained popularity within the orthopaedic community as a treatment modality to enhance tissue healing.
PURPOSE: This review aims to concisely present the current indications for PRP injections in the treatment of hip and pelvic pathologies and to describe some novel applications for PRP which have not yet been reported in the literature.
METHODS: We reviewed the literature on the non-operative and operative indications for PRP in the treatment of hip and pelvic pathologies.
CONCLUSIONS: With regard to hip and pelvic pathologies, PRP injections are used most commonly as a non-operative intervention, and have been described in the literature to treat osteoarthritis of the hip joint as well as tendinopathy of the hamstrings, adductor longus, and gluteus medius. In contrast, most of the surgical applications of PRP for the hip are novel, with few reported studies in the literature. Because of the increasing awareness of PRP's beneficial effects on musculoskeletal healing and thus the growing number of indications for its use, this review also describes some novel applications for PRP, including osteitis pubis, post-microfracture of the hip, tears of the rectus femoris, and avulsion of the sartorius muscle. LEVEL OF EVIDENCE: V.

Entities:  

Keywords:  hamstring tendinopathy; hip osteoarthritis; microfracture; osteitis pubis; platelet-rich plasma

Year:  2016        PMID: 28066748      PMCID: PMC5193533          DOI: 10.11138/mltj/2016.6.3.410

Source DB:  PubMed          Journal:  Muscles Ligaments Tendons J        ISSN: 2240-4554


  63 in total

1.  Effect of platelet-rich plasma on healing tissues in acute ruptured Achilles tendon: a human immunohistochemistry study.

Authors:  Joseph Alsousou; Mark Thompson; Paul Harrison; Keith Willett; Sarah Franklin
Journal:  Lancet       Date:  2015-02-26       Impact factor: 79.321

Review 2.  Common hip injuries in sport.

Authors:  K T Boyd; N S Peirce; M E Batt
Journal:  Sports Med       Date:  1997-10       Impact factor: 11.136

3.  High incidence of athletic pubalgia symptoms in professional athletes with symptomatic femoroacetabular impingement.

Authors:  Sommer Hammoud; Asheesh Bedi; Erin Magennis; William C Meyers; Bryan T Kelly
Journal:  Arthroscopy       Date:  2012-05-19       Impact factor: 4.772

4.  The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study.

Authors:  Scott A Rodeo; Demetris Delos; Riley J Williams; Ronald S Adler; Andrew Pearle; Russell F Warren
Journal:  Am J Sports Med       Date:  2012-04-10       Impact factor: 6.202

5.  Ultrasound-Guided Intratendinous Injections With Platelet-Rich Plasma or Autologous Whole Blood for Treatment of Proximal Hamstring Tendinopathy: A Double-Blind Randomized Controlled Trial.

Authors:  Kathleen L Davenport; Jose Santiago Campos; Joseph Nguyen; Gregory Saboeiro; Ronald S Adler; Peter J Moley
Journal:  J Ultrasound Med       Date:  2015-08       Impact factor: 2.153

6.  Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy.

Authors:  Taralyn M McCarrel; Tom Minas; Lisa A Fortier
Journal:  J Bone Joint Surg Am       Date:  2012-10-03       Impact factor: 5.284

7.  The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts.

Authors:  Filippo Graziani; Saso Ivanovski; Silvia Cei; Francesco Ducci; Maurizio Tonetti; Mario Gabriele
Journal:  Clin Oral Implants Res       Date:  2006-04       Impact factor: 5.977

8.  The anterior approach for a non-image-guided intra-articular hip injection.

Authors:  Omer Mei-Dan; Mark O McConkey; Brian Petersen; Eric McCarty; Brett Moreira; David A Young
Journal:  Arthroscopy       Date:  2013-04-13       Impact factor: 4.772

9.  Ultrasound-Guided Injection of Platelet-Rich Plasma and Hyaluronic Acid, Separately and in Combination, for Hip Osteoarthritis: A Randomized Controlled Study.

Authors:  Dante Dallari; Cesare Stagni; Nicola Rani; Giacomo Sabbioni; Patrizia Pelotti; Paola Torricelli; Matilde Tschon; Gianluca Giavaresi
Journal:  Am J Sports Med       Date:  2016-01-21       Impact factor: 6.202

10.  Leukocyte and Platelet Rich Plasma (L-PRP) Versus Leukocyte and Platelet Rich Fibrin (L-PRF) For Articular Cartilage Repair of the Knee: A Comparative Evaluation in an Animal Model.

Authors:  Davoud Kazemi; Ashraf Fakhrjou
Journal:  Iran Red Crescent Med J       Date:  2015-10-28       Impact factor: 0.611

View more
  5 in total

1.  Current hip cartilage regeneration/repair modalities: a scoping review of biologics and surgery.

Authors:  Mario Hevesi; George Jacob; Kazunori Shimomura; Wataru Ando; Norimasa Nakamura; Aaron J Krych
Journal:  Int Orthop       Date:  2020-09-10       Impact factor: 3.075

Review 2.  A proposed algorithm for the treatment of core muscle injuries.

Authors:  Matthew J Kraeutler; Omer Mei-Dan; Iciar M Dávila Castrodad; Toghrul Talishinskiy; Edward Milman; Anthony J Scillia
Journal:  J Hip Preserv Surg       Date:  2021-12-10

Review 3.  Treatment of Lateral Epicondylitis With Autologous Blood, Platelet-Rich Plasma, or Corticosteroid Injections: A Systematic Review of Overlapping Meta-analyses.

Authors:  Darby A Houck; Matthew J Kraeutler; Loree B Thornton; Eric C McCarty; Jonathan T Bravman
Journal:  Orthop J Sports Med       Date:  2019-03-14

4.  Ultrasound-Guided Cutting Wire Release of the Proximal Adductor Longus Tendon: A Feasibility Study.

Authors:  Brennan J Boettcher; John H Hollman; Michael J Stuart; Jonathan T Finnoff
Journal:  Orthop J Sports Med       Date:  2019-08-26

5.  Radiographic Factors Associated With Failure of Revision Hip Arthroscopy.

Authors:  David A Bloom; Stephen W Yu; Matthew T Kingery; Nainisha Chintalapudi; Christopher Looze; Thomas Youm
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.